By Peter A. McCullough, MD, MPH
Many colleagues challenged the inclusion of oseltamivir in the Contagion Emergency Kits offered by The Wellness Company. It has always been my clinical understanding that viral replication in any upper respiratory illness occurs early, and hence later administration captured in studies will bias to the null effect.
Bai et al studied a large group of elderly Canadians hospitalized with influenza, of whom 69% received oseltamivir.
Of 11 073 patients (mean [SD] age, 72.6 [16.8] years; 5793 female [52.3%]), there were 7632 patients (68.9%) and 3441 patients (31.1%) in the oseltamivir and supportive care groups, respectively. In hospital, 268 patients (3.5%) and 168 patients (4.9%) in the oseltamivir and supportive care groups died, respectively, with an adjusted risk difference of −1.8% (95% CI, −2.8% to −0.9%; P < .001). The oseltamivir treatment group was more likely to be discharged alive (adjusted subdistribution hazard ratio, 1.20; 95% CI, 1.15 to 1.25; P < .001). After discharge, 645 patients (8.5%) and 336 patients (9.8%) were readmitted in the oseltamivir and supportive care groups, respectively, with an adjusted risk difference of −1.5% (95% CI, −2.8% to −0.2%; P = .02).
I can tell you that a 28.6% reduction in mortality with oseltamivir is clinically meaningful particularly considering hospitalized patients receive other supportive care including intravenous fluids, secondary antibiotics, and oxygen etc.

Nowadays with rapid home influenza tests, elderly at-risk individuals should consider having a Wellness Company black Emergency Contagion Kit on hand which comes with a guidebook and telemedicine support. This will do a lot more than a flu-shot in helping our seniors survive the next flu season.
Please subscribe to FOCAL POINTS as a paying ($5 monthly) or founder member so we can continue to bring you the truth.
Peter A. McCullough, MD, MPH
Chief Scientific Officer, The Wellness Company
Click this link for the original source of this article.
Author: Peter A. McCullough, MD, MPH
This content is courtesy of, and owned and copyrighted by, https://petermcculloughmd.substack.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.